Blood cells or hemocytes are cellular components that mediate bivalve molluscan immunity. They float in the internal fluid or plasma in which organs are immersed. Consequently, hemocytes travel widely in the body cavity, providing ample opportunity to encounter foreign invaders. Hemocytes are capable of recognition through lectins (2, 3) and of chemotactic migration toward invading pathogens (4), followed by attachment and finally endocytosis of the pathogen (see Ref. 5 for a review). Two basic mechanisms for cell killing have been described in bivalve hemocytes. The first comprises the respiratory burst with release of highly reactive oxygen metabolites (6) . The second involves the release of lysosome enzymes from hemocytes (7) .
Mussel circulating hemocytes can be divided into basophilic and eosinophilic groups (8) , the former including hyaline (agranular) and granular cells and the latter only granular cells. Mussel granular hemocytes contain two different types of granules, distinguishable by size, lectin staining characteristics, and enzyme content (3, 9) . The presence of numerous hydrolytic enzymes including proteinases, glycosidases, and sulfatases housed in large granules suggests that they are related to lysosomes (9) .
In addition, cell free hemolymph contains various biologically active substances, including high molecular mass cytotoxic proteins capable of lysing various vertebrate erythrocytes (10) and recently discovered antimicrobial peptides. Three types of small sized, cationic, cysteine-rich peptides were characterized: mytilin (34 residues (1)), myticin (40 residues (11)), and peptides that are members of the large defensin family of insects (1, 12) . A novel cysteine-rich antifungal peptide (mytimycin) was also partially characterized (1) .
No information is available on precursor structure, localization, and regulation of antimicrobial peptide expression in mussels. This is in contrast to Drosophila, which responds to septic injury by rapid neosynthesis of antimicrobial peptides. These peptides, predominantly synthesized in the fat body, are secreted into hemolymph and participate in a systemic response (for a review, see Ref. 13 ). In addition, epithelial tissues that are in direct contact with the external environment also express the antifungal Drosophila peptide, drosomycin (14) , suggesting a local response to infections affecting these barriers. In vertebrates, some antimicrobial peptides are also produced by epithelial cells of the respiratory, gastrointestinal, and genitourinary tracts. Others are found in glandular secretions that moisten and lubricate epithelia (see Ref. 15 for a review). Antimicrobial peptides are especially abundant in certain phagocytes, migratory cells that can surround, ingest, and kill microbial invaders (see Ref. 16 for a review). Nevertheless, increased plasma levels of human ␣-defensins have also been observed in patients with septicemia or bacterial meningitis (17) , which supports the argument for participation of these peptides in systemic immune defense processes.
In the present report, we investigated the physiological roles of the mussel antimicrobial peptide mytilin. We report the purification of mytilin B and three isoforms from hemocytes, the activity spectrum, and bactericidal effect of the different isolated molecules. We examined precursor structure and distribution of mRNA and of the peptides in various mussel tissues. We analyzed subcellular localization of mytilins in hemocytes by electron microscopy. In an experimental model of infection, we obtained evidence for rapid migration of mytilincontaining cells toward injected bacteria. Furthermore, phagocytosis experiments and analysis at the ultrastructural level showed that ingested bacteria and mytilins are located in the same intracellular granules. Finally, we report increased plasma levels of mytilin B-like material in a later stage after bacterial challenge.
EXPERIMENTAL PROCEDURES

Mussels, Hemolymph Collection, Immune Challenge, and
Phagocytosis Assays
Adult mussels, Mytilus galloprovincialis, were collected from a marine farm (Palavas, France, Gulf of Lyon). After acclimatization in oxygenated sea water at 18 -20°C, hemolymph was collected approximately 0.5 ml/animal) with a syringe from the posterior adductor muscle, under 1 volume of anti-aggregant modified Alsever solution buffer (18) and immediately centrifuged at 800 ϫ g for 15 min at 4°C. Plasmas (cell-free hemolymphs) were then supplemented with aprotinin (5 g/ ml) and frozen (Ϫ80°C) until use, while cell pellets were dried and stored at Ϫ80°C until required. Mussels were challenged as follows. The shell was filed, and 100 l of heat-killed bacteria in sea water (10 8 Vibrio alginolyticus/ml) or 100 l of sterile sea water were injected into the adductor muscle. After challenge, mussels were returned to sea water, and hemolymph was collected periodically. Control hemolymphs were collected from unchallenged mussels.
For phagocytosis assays, hemolymph was harvested as above and kept in 14 ml of Falcon tubes. Heat-killed bacteria (V. alginolyticus) were immediately added, according to the ratio 50 bacteria:1 hemocyte, and incubation was performed during 20 min at room temperature. The cells were then centrifuged at 800 ϫ g for 15 min at 4°C, and the pellets were treated for immunocytochemistry (see below).
Peptide Extraction
Plasma was diluted (1:1, v/v) in ultrapure water (UPW) 1 containing 0.1% trifluoroacetic acid, and the pH was adjusted to 3.75 with 1 M HCl in ice-cold water bath under gentle stirring for 30 min. The supernatant was clarified by 20 min centrifugation at 10,000 ϫ g and then kept at 4°C until use. When extracting peptides from hemocytes, cell pellets were thawed and dissolved (5:1, v/v) in 50 mM Tris buffer, pH 8.7, containing 50 mM NaCl, and then homogenized (30 strokes) using a Dounce apparatus. After a 20-min centrifugation at 10,000 ϫ g, 4°C, the pellet containing cellular organelles was disrupted in 2 M acetic acid (3:1, v/v) by ultrasounds (3 ϫ 30 s) in an ice-cold water bath. Debris were eliminated by centrifugation (10,000 ϫ g, 20 min, 4°C), and the organelle acid extract was kept at 4°C until use.
Solid Phase Extraction Prepurification
Plasma or hemocyte organelle acid extracts were loaded onto SepPak C18 Vac cartridges (Waters Associates) equilibrated with acidified water (0.05% trifluoroacetic acid in UPW). After washing with acidified water, two successive elutions were performed with successively 5 and 40% acetonitrile in acidified water. The 5% fraction was discarded, and the 40% fraction was lyophilized and reconstituted with UPW.
HPLC Purification
All HPLC purification steps were carried out on a Beckman Gold HPLC system equipped with a Beckman 168 photodiode array detector. Column effluent was monitored by UV absorption at 225 nm. Fractions were hand-collected and treated for antimicrobial activity.
Step 1-The organelle acid extracts 40% Sep-Pak fraction were subjected to reverse-phase HPLC on a Sephasil C18 (250 ϫ 4.1-mm) column (Amersham Pharmacia Biotech). Elution was performed with a linear gradient of 5-55% acetonitrile in acidified water over 90 min at a flow rate of 0.9 ml/min. Fractions corresponding to absorbance peaks were collected in polypropylene tubes, freeze-dried, and reconstituted in UPW.
Step 2-Active fractions of step 1 were loaded onto a Sephasil C8 (250 ϫ 4.1-mm) column (Amersham Pharmacia Biotech) and eluted by two successive acetonitrile gradients over 10 and 40 min at a flow rate of 0.9 ml/min, according to the following peptide: mytilin B (5-20% and then 20 -30%), mytilin C (5-25.5% and then 25.5-35.5%), mytilin D (5-18% and then 18 -28%), mytilin G1 (5-23% and then 23-33%).
Step 3-Active fractions of step 2 were loaded onto a Sephasil C18 (250 ϫ 4.1 mm) column (Amersham Pharmacia Biotech) and eluted with the step 2 gradients.
Step 4 -To ascertain the purity of the peptides, one additional step was performed on a narrow bore Delta Pak HPI C18 (150 ϫ 2-mm) reverse-phase column (Waters Associates) at a flow rate of 0.3 ml/min using the gradients of step 2.
Mass Spectrometry and Sequencing
Ten l of purified peptides, corresponding to 50 pmol, were dissolved in UPW and analyzed by electrospray ionization in a Fisons mass spectrometer equipped with a quadrupole mass analyzer (mass range of 1-5000 Da). Molecular mass was calculated from a series of multiply charged protonated molecular ions. Purified peptides (0.5-1.5 nmol) were submitted to reduction and alkylation as described previously (10) . Automated Edman degradation was performed on a pulse-liquid automatic peptide sequencer Applied Biosystem 494. 
Microorganisms
Antimicrobial Assays
After each purification step, antibacterial activity was monitored by a liquid growth inhibition assay according to Bulet et al. (19) . Briefly, 10-l aliquots from each test fraction were incubated in microtiter plates with 100 l of a suspension of bacteria (M. luteus) at a starting optical density of A 600 ϭ 0.001 in Poor Broth nutrient medium (1% bactotrypton, 0.5% NaCl, w/v). Bacterial growth was assayed by measurement of optical density at A 600 after a 24-h incubation at 30°C. The minimal inhibitory concentration (MIC) was obtained by testing serial doubling dilutions of the peptides in the same conditions.
The minimal bactericidal concentration (MBC) was determined according to the method of Hancock (20) . Peptides were dissolved in a solution containing 0.01% acetic acid and 0.2% bovine serum albumin (BSA), and then serial doubling dilutions of the stock solution were made in 0.01% acetic acid, 0.2% BSA. Ten-l aliquots from each test dilution were incubated in sterile 96-well polypropylene microtiter plates with 100 l of a suspension of bacteria at a starting optical density of A 600 ϭ 0.001 in Mueller Hinton Broth medium (Difco). Bacterial growth was checked after 18-h incubation at 37°C under agitation, except for the marine bacteria which were incubated at 25°C in Mueller Hinton Broth medium supplemented with NaCl (15 g/liter). The MBC was determined by plating the contents of the first three wells with no visible growth of bacteria onto Mueller Hinton agar plates and incubating at 37°C for 18 h. The lowest concentration of peptide that prevented any residual colony formation corresponded to the MBC.
Antifungal activity was monitored against F. oxysporum as described by Fehlbaum et al. (21) by a liquid growth inhibition assay. Briefly, 80 l of fungal spores (final concentration, 10 4 spores/ml) suspended in potato dextrose broth (Difco) were added to 10 l of peptide solution in microtiter plates. Growth inhibition was observed microscopically after a 24-h incubation at 30°C and quantified by measurement of optical density at 600 nm after 48 h. The MIC values are expressed as an interval of concentration (a-b), where (a) represents the highest peptide concentration at which fungi are still growing and (b) the lowest concentration that causes 100% growth inhibition.
To test anti-protozoan activity, P. marinus was cultivated in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) according to the method of Gauthier and Vasta (22) . Pure peptide (10 M) was added to 4 ϫ 10 4 P. marinus in sea water (final volume 20 l) and incubated for 1 h at room temperature. Parasite viability was then estimated using acridine orange and ethidium bromide (23) .
Bactericidal Assay
Ten l of purified peptide, at a concentration 10 times the MIC, was mixed with 90 l of an exponential phase culture of M. luteus at a starting A 600 ϭ 0.01 in Poor Broth nutrient medium and incubated at 30°C. Aliquots of 10 l were plated after 0-min, 3-min, 10-min, 30-min, 2-h, 6-h, and 24-h incubation times on nutrient agar plates, and the number of colony-forming units was established after overnight incubation at 37°C. As a control, the bacterial culture was incubated with 10 l of sterile water.
Mytilin B, Actin, and Ribosomal 18 S DNA Probes and Screening of cDNA Library
A cDNA library was constructed in the ZAP Express vector (Stratagene) using Poly(A) ϩ RNA from unchallenged adult mussel hemocytes. Reverse transcription-PCR was used to prepare the DNA probe corresponding to mytilin B. From the mytilin B amino acid sequence obtained by Edman degradation, degenerate sense oligonucleotides corresponding to residues 4 -10 (5Ј-TT(C/T)(A/C)GITG(C/T)AA(A/G)GGITA-(C/T)TG-3Ј) and degenerate antisense oligonucleotide corresponding to the residues 26 -32 (5Ј-A(A/G)(C/T)TT(C/T)TT(A/G)CA(A/G)TA(A/G)C-AIC-3Ј) were designed by back translation. Three g of total RNA were submitted to reverse transcription using the Ready-to-Go You-Prime First-Strand Beads kit (Amersham Pharmacia Biotech). One-fifth of the reaction was directly used as a template for the PCR with the two degenerate pool primers. PCR was performed with 40 cycles consisting of 1 min at 94°C, 1 min at 48°C, and 1 min at 72°C in 1.5 mM MgCl 2 and 1 M primers.
The resulting 83-base pair cDNA fragment corresponding to mytilin B was cloned using the PCR script Amp (SKϩ) cloning kit (Stratagene), and the plasmid was called pBSMyt.83. The insert was labeled by random priming using the Ready-to-Go DNA labeling kit (Amersham Pharmacia Biotech) and used to screen 400,000 plaques from the cDNA library transferred to Hybond-N filter membranes (Amersham Pharmacia Biotech). High stringency hybridizations were carried out overnight at 65°C in 5ϫ Denhardt's solution, 5ϫ SSPE, 0.1% SDS, 100 g/ml salmon sperm DNA. The filters were washed in a solution of 0.5ϫ SSC containing 0.1% SDS at 65°C, followed by autoradiography. A secondary screening was performed to purify the positive clones. Phagemids were obtained by in vivo excision according to the manufacturer's instructions and sequenced on both strands.
18 S ribosomal DNA probe sense oligonucleotide (5Ј-TGACCTCGCG-GAAAGAGCGC-3Ј) and antisense oligonucleotide (5Ј-AGGGGACGTA-ATCAACGCGAGC-3Ј) were designed from the sequence of the ribosomal RNA small subunit (24) and used in PCR experiments. Five hundred ng of mussel genome DNA were submitted to amplification using 35 cycles consisting of 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C in 1.5 mM MgCl 2 and 1 M primers.
The preparation of hemocyte actin cDNA was reported in another study. 2 
Northern Blot Analysis
Hemocytes from four mussels (8 ϫ 10 6 cells/animal) were pooled, centrifuged, and suspended in 1 ml of Trizol (Life Technologies). Immediately after hemolymph collection, the mantle, foot, labial palps, gills, hepatopancreas, and adductor muscle were excised from the same mussels and washed extensively in sterile sea water. Tissues (100 mg of each) were homogenized in 1 ml of Trizol using 30 potter strokes, and total RNA was extracted using the manufacturer's protocol. Five g of total RNA from each tissue and from each mussel were pooled (20 g of total RNA/tissue) and subsequently analyzed.
For kinetics analysis, hemocytes were collected from noninjected and from bacteria or saline-injected mussels from 0 to 48 h postinjection. Hemocytes from each set of 30 mussels were centrifuged and suspended in 1 ml of Trizol. Total RNA was obtained according to the manufacturer's instruction, and 20 g of total RNA from each set were submitted to analysis.
Total RNAs from tissues and hemocytes were separated on 1.2% agarose gel containing 17% formaldehyde and transferred to Hybond N membrane (Amersham Pharmacia Biotech). Membranes were hybridized with 32 P-labeled mytilin B cDNA fragment in a solution containing formamide (50%), 5ϫ SSC, 8ϫ Denhardt's solution, 0.05 M sodium phosphate, pH 6.5, 0.1% SDS, 100 g/ml salmon sperm at 55°C for 12 h. Membranes were washed in 0.2ϫ SSC, 0.1% SDS at 65°C, and autoradiography was carried out. Size markers were simultaneously applied to the electrophoresis and stained with a methylene blue solution. After autoradiography the membranes were stripped (boiling solution of 0.1% SDS onto the blot) and submitted to the same protocol for the 32 P-labeled ribosomal DNA probe or 32 P-labeled actin cDNA probe.
Anti-mytilin B Antibody
Pure mytilin B peptide (0.6 mg) was coupled to ovalbumin using glutaraldehyde. Briefly, an equal volume of 0.2% glutaraldehyde in PBS was added to a solution containing ovalbumin and mytilin B (3:1, w/w) in PBS. After a 1-h incubation at room temperature with constant agitation, glycine was added to a final concentration of 200 mM, and the reaction was incubated with stirring for another hour. Two rabbits (male, 2-3 kg) were immunized by intradermal injection of 1 ⁄4 of the peptide mixture and Freund's complete adjuvant followed by three intradermal injections of 1 ⁄4 of the peptide mixture each with Freund's incomplete adjuvant at 2-or 3-week intervals. The antiserum was collected 10 days after the last injection and IgG were purified on a Hitrap protein G Sepharose column (Amersham Pharmacia Biotech).
Immunocytochemistry
For light microscopy, hemolymph was collected under 1 volume of anti-aggregating modified Alsever solution (18) containing 8% paraformaldehyde. After a 10-min fixation at room temperature, cells were centrifuged (5 min, 1000 rpm) on slides (Cyto-Tek centrifuge), immersed in a 25 mM Tris buffer containing 0.2% gelatin, 0.5% Triton X-100, 50 mM ammonium chloride for 10 min and then in a pH 7.4 PBS buffer containing 5% gelatin hydrolysate (Bellon, France) and 1% normal goat serum (NGS; Sigma) for 1 h. Cells were then successively incubated with the anti-mytilin B antibody (10 g/ml) for 1 h at room temperature and with a fluorescein isothiocyanate anti-rabbit IgG (BioSys) diluted 1:500 in the presence of Evans blue for 25 min at room temperature. Slides were mounted in glycerin buffer and observed by epifluorescence.
To study the immune reactivity on mussels, tissues from adults were fixed in a solution containing 35% formalin, 39% ethanol, and 0.65% ammonium hydroxide, pH 6.4. After dehydration, tissues were embedded in Paraplast, and 4-m sections were cut, mounted on poly-Llysinated slides, and stored at 4°C in a dry atmosphere. After hydration, the sections were treated at room temperature as follows: (i) 10 min in PBS; (ii) 1.5 h in PBS containing 5% gelatin hydrolysate and 1% NGS (PBS/gelatin hydrolysate/NGS); (iii) 1 h in anti-mytilin B IgG at 10 g/ml in the preceding buffer; (iv) 1 h in alkaline phosphatase-labeled goat anti-rabbit IgG (BioSys) diluted 1:300 in the preceding buffer; (v) 10 min in equilibration buffer III (100 mM Tris-HCl, 100 mM NaCl, and 50 mM MgCl 2 , pH 9.5); (vi) 20-min development in buffer III containing 0.19 mg/ml 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mg/ml nitro blue tetrazolium, and 0.24 mg/ml levamisole; (vii) the reaction was stopped by a 15-min incubation in buffer IV (1 mM Tris-HCl and 1 mM EDTA, pH 8). Sections were mounted in Eukitt and observed using a light microscope.
For electron microscopy and light microscopy of semithin sections, cell pellet (10 7 cells) and dissected tissues were fixed for 2 h at 4°C in a mixture of 4% paraformaldehyde, 0.2% picric acid, and 0.1% glutaraldehyde in PBS. Cells and tissues were postfixed in 1% OsO 4 for 5 min and dehydrated before embedding in LR White (TAAB Laboratories).
For light microscopy, immune staining was performed on 1-m-thick sections of tissues, placed on glass slides in a small drop of distilled water, and dried on a heating plate (100°C for 5 min). Slides were treated as follows: (i) 30-min preincubation in TBS (0.1 M Tris-HCl, pH 7.4, 0.9% NaCl) containing 1% NGS and 1% BSA; (ii) 14-h incubation at 4°C with 10 g/ml anti-mytilin B IgG in TBS containing 1% NGS and 1% BSA (TBS/NGS/BSA); (iii) three 5-min washes in TBS; (iv) 1. Controls, which consisted of preabsorbing the antibody overnight at 4°C with pure mytilin B (10 g of mytilin B per g of purified IgG), were performed on centrifuged hemocytes, paraffin, and semithin sections.
ELISA
Mytilin B-like substances present in 40% Sep-Pak fraction of plasmatic extracts were quantified by ELISA. All washing procedures were performed three times with PBS containing 0.1% Tween 20. Antibodies were diluted in PBS, 5% gelatin hydrolysate, 0.1% Tween 20, and all of the incubations were carried out in a volume of 100 l/well.
Two g of the 40% Sep-Pak fractions or serial dilutions of native mytilin B peptide solution were diluted in 0.05 M Na 2 CO 3 , pH 9.6, and coated on flat-bottomed 96-well microtiter plates (Falcon 3912) during one night at 4°C. After washing, PBS with 20% gelatin hydrolysate was added to each well and incubated for 1 h at room temperature, and washed wells were then incubated with the anti-mytilin B antibody at a concentration of 10 g/ml during 1.5 h at 37°C. After washing, a new incubation was performed with an alkaline phosphatase-labeled antirabbit IgG antibody (BioSys) diluted 1:4000 during 1 h at 37°C. Finally, and after washing, 100 l of 1 mg/ml p-nitrophenyl phosphate and 0.2 M Tris-HCl, pH 9.8, was added for 30 min at room temperature. The color density was measured at 405 nm using a Multiskan (Labsystem).
RESULTS
New Mytilin Isoforms Are Abundant in Hemocyte
Organelles-Mytilins were purified from organelle acid extracts prepared from 2 ϫ 10 9 hemocytes collected from 1,000 mussels. Elution from Sep-Pak C18 performed with 5% acetonitrile was discarded as containing no antimicrobial activity. The 40% eluate was applied to reverse-phase HPLC and fractionated using a linear gradient of 5-55% acetonitrile over 90 min (0.56% acetonitrile/min). Activities against M. luteus and F. oxysporum were assayed all along the elution gradient, revealing an active zone ranged between 20 and 33% of acetonitrile (Fig. 1A) . The present study focuses on the fractions H2, H4, H6, and H7 (Fig. 1A) . These fractions were submitted to three additional reverse-phase HPLCs. The active peptide present in fraction H2 (80 g) possessed a mass of 3,868.65 Ϯ 0.35 Da. Complete sequence revealed the presence of eight cysteines (Fig. 1B) with a calculated mass of 3,877.79 Da, in agreement with the observed mass considering the formation of four disulfide bridges. Only one amino acid is different (Arg in position 25 instead of Gly) when compared with mytilin A (Fig. 1C) , a peptide of 3,773.7 Da previously characterized from the plasma of Mytilus edulis (1) . Consequently, the H2 peptide constitutes a new mytilin isoform, named mytilin D. Using the same strategy, we have isolated from fraction H7 another new isoform of 4,287.05 Ϯ 0.29 Da (900 g), named mytilin C. Partial NH 2 -terminal sequence was obtained revealing seven cysteines (Fig. 1B) , but the sequencing signal was so low after Cys 31 that the last amino acids were not definable. Fraction H6 contained a peptide of 4,118.25 Ϯ 0.26 Da sharing the mytilin consensus cysteine array (Fig. 1B) but composed of 36 residues and exhibiting limited homologies with the other mytilins (Fig.  1C) . For these raisons, we named it mytilin G1 for galloprovincialis 1. Considering the formation of four disulfide bridges, its calculated mass of 4,118.03 Da is in full agreement with the mass measured on the native peptide. Finally, a peptide of 3,973.09 Ϯ 0.95 Da (650 g) was purified to homogeneity from fraction H4. Complete sequence (Fig. 1B) revealed its identity to mytilin B, a molecule already isolated from the plasma of M. edulis (1) (Fig. 1C) .
Different Antimicrobial Activities According to IsoformsAmounts of purified mytilin B (164 nmol), C (210 nmol), D (20 nmol), and G1 (31 nmol) were sufficient to establish their activity spectrum (Table I ). In liquid growth inhibition assays, mytilins B, C, and D had marked activity against both Grampositive and Gram-negative bacteria. Nevertheless, mytilin G1 appeared differently, active only on Gram-positive bacteria. Among the Gram-positive bacteria, mytilin isoforms exerted different intensity of activities: MBC of mytilin C on E. faecalis luteus. In addition, mytilin C is four times more active (MBC ϭ 0.7-1.4 M) than mytilin D (MBC ϭ 2.8 -5.6 M) on S. aureus, whereas mytilin B and G1 are not active even at 5.6 M.
Strong differences were also observed concerning activities on Gram-negative bacteria. No activity was found for mytilin G1, whereas all other mytilins are active especially on marine Vibrio with similar MBC. Nevertheless, mytilin B is 8 times less active on V. splendidus (MBC ϭ 0.17-0.35 M) than mytilin C (1.4 -2.8 M) . Mytilins B and D were also active against the filamentous fungus F. oxysporum (MIC ϭ 0.7-1.4 M), but no activity was found for mytilins C and G1, even at 5.6 M.
FIG. 1. Reverse-phase HPLC of acidic extracts obtained from hemocyte granules (A), NH 2 -amino acid sequences of the purified molecules (B), and alignment of all known mytilins (C).
A, the fraction eluted from Sep-Pak C18 with 40% acetonitrile was loaded onto an Amersham Pharmacia Biotech Sephasil C18 column. Elution was performed with a 5-55% linear gradient (dotted line) of acetonitrile over 90 min at a flow rate of 0.9 ml/min. Absorbance peaks were monitored at 225 nm (solid line). Antimicrobial activities against M. luteus (open rectangles) and F. oxysporum (gray shaded rectangles) were detected by liquid growth inhibition assays. Fractions containing the peptides characterized in this study are indicated by arrows. B, peptides were submitted to sequencing by Edman degradation after reduction and alkylation. The three peptides present in the fractions H2, H6, and H7 were three new isoforms of mytilin called mytilin D, G1, and C, respectively. Fraction H4 contained mytilin B, a molecule already characterized from mussel plasma (1) . Cysteines are in boldface and gray letters. C, comparison of mytilin C, D, and G1 isolated in this study with mytilin A and B. Identical residues are highlighted and cysteines are boxed with the consensus cysteine array deduced from mytilin sequences.
Only mytilin C was tested against the protozoan parasite, P. marinus, which appeared unaffected at least until 20 M.
All the mytilins exerted bactericidal effects, but kinetics differences were noted (Table II) . When the different isoforms were incubated with M. luteus at concentrations 10 times higher than the MIC, more than 2 and 6 h was necessary for mytilins D and G1, respectively, to kill all bacteria, whereas only a few minutes in the presence of mytilins B and C was enough to kill all bacteria.
Original Structure of Mytilin B Precursor-An 83-base pair fragment corresponding to mytilin B was obtained by reverse transcription-PCR and used to screen a hemocyte cDNA library. Among the 72 clones obtained, four were sequenced. They had the same sequence, and only the longest is detailed further on. The cDNA included 524 nucleotides and contained an open reading frame encoding a 103-amino acid sequence (Fig. 2) . Deduced amino acid sequence begins with a 22-residue signal peptide with a typical hydrophobic core. The cleavage site for signal peptidase is most likely located after the alanine residue preceding the serine in position 1 of mature peptide as predicted by Signal P version 1.1 software (25) . The sequence following the cleavage site corresponded to the mature peptide and clearly confirmed the mytilin B sequence obtained by biochemical methods. Unexpectedly, the open reading frame also coded for a 47-residue C-terminal extension peptide. This Cterminal peptide is acidic, since 11 residues out of 47 are aspartic or glutamic acids.
Localization of Mytilin B Precursor and Transcriptional Profiles after Bacterial
Challenge-Analyzed on Northern blot, only hemocyte RNA exhibited one band that hybridized with the mytilin B cDNA insert (Fig. 3A) . The length of this RNA was estimated to be about 0.65 kb.
Kinetics of expression following bacterial challenge was analyzed by Northern blot in hemocytes collected 7, 24, and 48 h after bacteria or saline injection. The bacteria strain used for immune challenge was V. alginolyticus, a pathogen for mussel larvae but not for adults (26) . No significant increase of the transcription level was observed, whatever the considered injection (Fig. 3B) . On the contrary, very low levels of mytilin transcripts were detected 7 h and especially 24 h after bacteria injection, revealing that mytilin mRNA concentration was decreased by bacterial challenge. Nevertheless, the normal level of expression was reached 48 h after injection.
Mytilins Are Stored in Hemocyte Subtype Containing Large Granules-The high degree of homology between the different isoforms of mytilins implies that our anti-mytilin B antibody probably recognized different isoforms. Nevertheless, quantification by ELISA of the amount of recognized peptide showed that the limit of detection was approximately 9, 14, and 23 times higher for mytilins D, C and G1, respectively, than for mytilin B.
Immunofluorescence performed on hemocytes collected from circulation revealed that only some hemocytes are positive for mytilins (Fig. 4A) . Evans blue counterstaining indicated that the labeling was restricted to one hemocyte subtype. Preadsorption of anti-mytilin B antibody with mytilin B abolished the positive staining (Fig. 4B) , reflecting specificity of the immune staining for mytilins. On paraffin sections of the entire body, mytilin immune reactivity was found in some hemocytes present in sinuses of the adductor muscle (Fig. 4C), gills (Fig.  4D) , digestive gland (Fig. 4E) , and intestine (Fig. 4F) . Numerous immune positive cells also infiltrated the epithelia of gills (Fig. 4D) , digestive gland (Fig. 4E), and intestine (Fig. 4F) . The shape of these cells and Wright's staining characteristics (data not shown) suggested that in epithelia, positive cells were 
TABLE II Bacteriolytic effect of mytilin B, C, D, and G1 on M. luteus
Peptides at a final concentration 10 times higher than the MIC (7 M for mytilin C and G1 and 2 M for mytilin B and D) or water (control) was added to an exponential growth phase culture of M. luteus. Aliquots were removed at various times, and the number of colony-forming units/ml (cfu/ml) was determined after overnight incubation on LB agar plates at 37°C. infiltrating hemocytes. This was confirmed on semithin sections of intestine and digestive gland, where mytilin immune reactivity was observed in cells having morphological features of hemocytes (Fig. 4, G and H) . Investigated in electron microscopy using 10-nm gold particles, mytilin labeling was exclusively present in hemocytes exhibiting large granules (Fig. 5) . Although three types of granules (multivesicular (3-8 m) , large (0.5-1.5 m), and small (0.2-0.3 m)) were observed in this type of cells, gold particles were present only in multivesicular and large granules (Fig. 5,  A, B, and E) . Furthermore, exocytosis of large granules was observed (Fig. 5C) . No mytilin immune reactivity was found in the other two hemocyte subpopulations, i.e. granulocytes containing small granules and hyalinocytes.
Hemocyte Recruitment and Co-localization of Mytilin and Phagocytosed Bacteria-Injections of V. alginolyticus into the adductor muscle resulted in a dramatic decrease of circulating hemocytes as soon as 1 h postinjection (Fig. 6A) and lasted for at least 24 h. In contrast, saline injection did not modify the concentration of circulating hemocytes. The decrease could result from adherence to internal structures following cell activation. To investigate this possibility, sections of adductor muscles were observed 5 h postinjection. Fig. 6B revealed the accumulation of mytilin-positive hemocytes around the injection site in 8 out of 14 mussels injected with bacteria. No accumulation was observed in any of the saline-injected mussels.
The relationship between mytilins and bacteria was investigated incubating hemocytes for 20 min in the presence of V. alginolyticus and then observed in electron microscopy. Hemocytes containing mytilin reactivity were the only ones capable of phagocytosis. No bacteria were observed in mytilin-negative cells. Furthermore, mytilin reactivity co-localized with bacteria in the same organelles, probably phagolysosomes (Fig. 5, D  and F) .
Plasma Level of Mytilin-like Material Increased 48 h after Bacterial Challenge-Plasma levels of mytilin-like material were determined between 3 and 72 h after bacterial challenge (10 8 bacteria/mussel). Pooled hemolymph (20 ml) from 30 mussels was acidified and loaded on Sep-Pak C18 cartridges. The 40% acetonitrile fraction was submitted to ELISA with antimytilin B antibody. Concentration of mytilin-like material was 1.01 Ϯ 0.29 and 10.85 Ϯ 0.77 ng/g of 40% Sep-Pak fraction for the controls and injected mussels 48 h after bacterial challenge, respectively (Fig. 7) . Considering the mean value of the amount of 40% Sep-Pak fraction (g) per volume of plasma (ml), the concentration of mytilin-like material was approximately 2.96 and 44.14 ng/ml in control and bacteria-injected mussels, respectively. Considering the molecular mass of mytilins (about 4 kDa), the concentration of mytilin-like material was estimated at 10 M in the plasma of challenged mussels.
DISCUSSION
We report here the characterization of four cysteine-rich antimicrobial peptides from the hemocytes of M. galloprovincialis. One of them, mytilin B, has already been characterized from the plasma of M. edulis (1) . The three other peptides represent distinct isoforms and are called mytilin C, D, and G1.
The various mytilin isoforms possess distinct specific activities. For instance, mytilin B and C display different activities against the fungus, F. oxysporum, and the bacteria, V. splendidus, pathogen for marine crustaceans (27, 28) and bivalve molluscs (29) , respectively, even if they share a high degree of homology in their primary structure. In fact, the different isoforms possess complementary properties that could represent the biological significance of such a diversity. Furthermore, other molecules, such as antibacterial defensins, antibacterial and antifungal myticins, and antifungal mytimycin (1, 12) , also participate in the defense, increasing the antimicrobial capabilities of mussels confronted with a high diversity of pathogens.
Mytilin B is processed from a precursor molecule consisting of a presegment of 22 amino acid residues, a mature peptide of 34 amino acid residues, and a C-terminal sequence of 48 residues rich in acidic amino acids. While the presegment is presumed to be a signal sequence for translocation to the lumen of the rough endoplasmic reticulum, the functional significance of the anionic C-terminal portion is unknown. This region might interact with a cationic part of the peptide (i) to stabilize the conformation of the precursor suitable for proteolytic processing or (ii) to protect the producing cell from membrane interaction with the basic region of the peptide. The C-terminal FIG. 5 . Ultrastructural distribution of mytilin B immune reactivity in hemocytes. Hemocytes were fixed, embedded in LR White, and immunostained for mytilin using a 10-nm gold particle-conjugated secondary antibody. Numerous gold particles are present in large electron dense and multivesicular granules with no labeling throughout the cytoplasm and nucleus (A and B). Small and clear granules are usually also not labeled (B and E). When hemocytes were first incubated for 20 min with bacteria and then submitted to the detection of mytilin B, bacteria and immune reactivity were observed within the same organelles (D and F). These organelles may contain nonimmune reactive clear granules (F). Immune reactive dense material often surrounds the phagocytosed bacteria. C, image suggesting exocytosis of a large granule. b, bacteria; mv, multivesicular granule; n, nucleus; p, phagolysosomes. Bar, 0.5 m. (2) were injected. Muscles were dissected 5 h after injection, fixed, and embedded in paraffin. Immune reactivity was detected using anti-mytilin B antibody detected by secondary antibody labeled with alkaline phosphatase.
sequence could also function as a signal to address the peptide to a particular hemocyte compartment. Similar C-terminal extension is not frequent, but it has also been observed in the tachyplesin precursor from the horseshoe crab, Tachypleus tridentatus (30) .
Biochemical purification from hemocyte granules indicated that hemocytes are responsible for mature mytilin storage. In addition, mytilin cDNAs were isolated from hemocyte mRNA, and Northern blot analysis confirmed that hemocytes are also the site of mytilin precursor synthesis. This implies that mytilins are processed to active compounds within hemocytes as reported in arthropods, horseshoe crabs (T. tridentatus) (30) , and shrimps (Penaeus vannamei) (31) . Mytilin immune reactivity is located in both large and multivesicular granules contained in a specific hemocyte subtype, which are in the circulatory system and infiltrating some tissues. Mytilin-positive cells are particularly abundant in epithelia in contact with the external environment, probably constituting a first barrier preventing pathogen entry.
Subjecting mussels to bacterial challenge resulted in a transient decrease in mytilin B messenger concentration in circulating hemocytes. One explanation of this decrease considers an apoptotic phenomenon of the mytilin-producing cells after phagocytosis of bacteria. Such a mechanism of cell death has been described for human neutrophils following ingestion of E. coli (32) . Another explanation could be the recruitment of mytilin-producing cells toward sites of injection. Immunohistochemistry revealed a migration and adherence of the hemocytes containing mytilin around the injection site arguing in favor of a local participation of mytilins in antimicrobial responses. The peptides could (i) be massively secreted into the immediate hemocytic environment or (ii) exert their microbicidal activity on engulfed bacteria. To distinguish between these two hypotheses, hemocytes were confronted with bacteria in vitro. Only the mytilin-positive cell type was able to phagocytose the bacteria, and phagocytosed bacteria were co-localized with mytilin reactivity in the same organelles, probably phagolysosomes. Exocytosis pictures of large granules suggested possible release of mytilins. In fact, mytilin B was previously isolated from plasma (1), and our data concerning increase in plasma level of mytilin B material also argued in favor of a participation of mytilins in a later systemic response.
A different regulatory system operates in insects, where expression of genes encoding antibacterial peptides is induced by bacterial challenge and shows similarities with that of the mammalian acute phase response (see Ref. 33 for a review). In the horseshoe crab, hemocytes produce and store immune mediators in granular structures. However, upon stimulation by microbial substances such as lipopolysaccharides and ␤-glucans, hemocytes degranulate and release into the plasma a series of substances involved in immune defense (see Ref. 34 for a review), including several antimicrobial peptides such as tachyplesin (30) , big defensin (35) , and tachycitin (36) . By contrast, the mussel model exhibits similarities with that described for human neutrophil ␣-defensin peptides. Human neutrophil ␣-defensin peptides are not massively secreted into the blood, but these molecules accumulate in granulocytes and certain macrophages to exert their microbicidal activity on engulfed bacteria (16) . Nevertheless, increased plasma levels of human defensins have been reported associated with septicemia or bacterial meningitis (17) , suggesting a systemic antimicrobial response.
In conclusion, our data strongly suggest that mytilins are implicated in response to infections. They are transported within hours by hemocytes toward the injection site. They co-localized with engulfed bacteria, suggesting a microbicidal activity. Later, their concentration increased in the plasma, probably by hemocyte degranulation, for a systemic antimicrobial response. Such a release of mytilins allowed plasma concentrations superior to the MBC values necessary to kill most of the bacteria. However, mytilins represent only one type of mussel antimicrobial molecules, since several others are also present in hemocytes and/or plasma (1, 9 -12) . Such a diversity, extended by the presence of isoforms, allows us to question the views of primitive and nonspecific invertebrate defense systems. FIG. 7 . Time course of mytilin-like material in plasma of bacteria-injected mussels. Plasma from sets of mussels (30 mussels per condition) was collected at different times after bacterial or saline injection, acidified, and fractionated onto Sep-Pak C18 cartridges. Mytilin-like material present in 40% Sep-Pak fractions was quantified by ELISA. Histograms show mytilin-like material concentrations in fractionated hemolymph harvested 3, 6, 24, 48, and 72 h after saline (open bars) or bacterial (black bars; 10 7 bacteria/mussel) injection. The control (gray bar) represents concentration in fractionated hemolymph harvested from untreated animals. Each value represents the arithmetic mean value obtained from three different experiments.
